THRIVE Use in Pediatric Populations- Multi Site

NACompletedINTERVENTIONAL
Enrollment

175

Participants

Timeline

Start Date

October 21, 2020

Primary Completion Date

January 19, 2024

Study Completion Date

January 19, 2024

Conditions
Oxygen DeficiencyDesaturation of BloodHypoventilationAnesthesia; Adverse Effect
Interventions
DEVICE

Transnasal Humidified Rapid-Insufflation Ventilatory Echange

The use of high-flow nasal cannula to augment the ability to oxygenate and ventilate a patient under general anesthesia.

Trial Locations (5)

22903

The University of Virginia, Charlottesville

45229

Cincinnati Children's Hospital, Cincinnati

60611

Lurie Children's Hospital of Chicago, Chicago

94304

Lucile Packard Children's Hospital Stanford, Palo Alto

02114

Massachussetts Eye and Ear Harvard Medical School, Boston

All Listed Sponsors
collaborator

Nationwide Children's Hospital

OTHER

collaborator

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER

collaborator

Boston Children's Hospital

OTHER

collaborator

UC Davis Children's Hospital

UNKNOWN

lead

Stanford University

OTHER

NCT04322994 - THRIVE Use in Pediatric Populations- Multi Site | Biotech Hunter | Biotech Hunter